T2 could save lives – bottomline.

  • Get patients on the right therapy faster
  • Improve morbidity and mortality outcomes
  • Reduce costs
  • Improve antimicrobial stewardship


Now, hospitals can detect and identify sepsis-causing pathogens faster and more accurately.

Hospitals trust in T2 technology.




reduction in antifungal therapy.

Learn More

Henry Ford Health System


7 days

reduction in median length of stay in the ICU.

Learn More

Lee Health

T2Bacteria positive results

20 hours

sooner than blood culture.

Learn More

Huntsville Hospital



pharmacy costs per patient.

Learn More

Robert Wood Johnson Medical School

Identified escalation and
de-escalation opportunities in patients tested with T2Candida.

Learn More

Riverside Community Hospital 


of patients who tested positive received appropriate therapy in <9 hours

Learn More

Hospitals trust in T2 technology.

Gregorio Marañón Hospital in Madrid, Spain

Two 2018 studies 

from Gregorio Marañón Hospital in Madrid, Spain.

Learn More

Rigshospitalet, Denmark

"T2Candida was superior to blood culture and mannan antigen and may improve diagnosis." Learn More

Gemelli Hospital, Italy


of the clinically infected patients missed by blood culture were correctly identified by T2Bacteria Learn More

La Paz Hospital University, Spain

T2Candia Panel

contributed to the healthy discharge of a 1-year-old transplant patient. Learn More

Patient Case Studies

Real stories about how T2Direct Diagnostics™ could have potentially changed clinical practice and patient outcomes.

Patient case studies

Real stories about how T2 Biosystems panels could have potentially changed clinical practice and patient outcomes.

Numbers don't lie.


Cost of sepsis

$41 billion in US healthcare costs

Sepsis kills

~11 million people worldwide annually.

Sepsis contributes to

1 in 5 US hospital deaths.
Integrate T2 Biosystems panels into your hospital today!
Learn More

19th-Century diagnostic methods make it too easy for “ESKAPE” pathogens to escape

In 2004, microbiologist Carl Nathan, M.D., wrote in a Nature commentary that: “Treating infections with pathogen-specific rather than br...More